Prosecution Insights
Prosecution Insights
Tech Center 1600 • Art Units: 1624
This examiner grants 76% of resolved cases
| App # | Title | Status | Assignee |
|---|---|---|---|
| 18251111 | CRYSTALLINE FORM IV OF MELANOCORTIN RECEPTOR AGONIST COMPOUND AND PREPARATION METHOD THEREFOR | Non-Final OA | LG CHEM, LTD. |
| 18018207 | ARYL SUBSTITUTED PYRROLO-PYRIDINONES AND THERAPEUTIC USES THEREOF | Non-Final OA | Dana-Farber Cancer Institute, Inc. |
| 18255767 | COMPOUNDS AND THEIR USE FOR TREATING NEUROPATHIC PAIN | Non-Final OA | The Johns Hopkins University |
| 17430077 | MONONUCLEAR IRIDIUM COMPLEXES CONTAINING THREE ORTHO-METALLATED BIDENTATE LIGANDS AND OPTICAL ORIENTATING ANISTROPHY | Non-Final OA | UDC IRELAND LIMITED |
| 18268102 | METHODS OF TREATING NEURODEGENERATIVE DISORDERS AND STAT3-LINKED CANCERS USING SUPPRESSORS OF ELECTRON LEAK | Non-Final OA | Cornell University |
| 18320470 | REPOSITIONING THE ANTI-LEPROSY DRUG CLOFAZIMINE AGAINST DRUG-RESISTANT MYELOMA AND PUTATIVE STEM-CELL SUBCLONES | Final Rejection | Auburn University |
| 17906742 | AMINOPYRIMIDINE DERIVATIVES AND THEIR USE AS ARYL HYDROCARBON RECEPTOR MODULATORS | Final Rejection | DONG-A ST CO., LTD. |
| 18289476 | NOVEL TRYPTAMINES AND METHODS OF TREATING MOOD DISORDERS | Non-Final OA | GILGAMESH PHARMACEUTICALS INC. |
| 18556309 | FATTY ACID LACTYLATES FOR USE IN TREATING RUMINANT ANIMALS | Non-Final OA | PURAC BIOCHEM B.V. |
| 18270288 | Anti-Tumor Compositions and Methods | Non-Final OA | Evrys Bio, LLC |
| 18269783 | PHARMACEUTICAL COMPOSITION CONTAINING PYRROLOQUINOLINE QUINONE TRILITHIUM SALT NONAHYDRATE COMPOUND, CAPSULE, AND PREPARATION METHOD THEREFOR | Non-Final OA | SHANGHAI RAISING PHARMACEUTICAL CO., LTD |
| 17790835 | AURISTATIN-RELATED COMPOUNDS, CONJUGATED AURISTATIN-RELATED COMPOUNDS, AND METHODS OF USE THEREOF | Final Rejection | CYTOMX THERAPEUTICS, INC. |
| 17605676 | NUCLEOSIDE DERIVATIVE FOR PREVENTING AND TREATING INFLAMMATION AND APPLICATION THEREOF | Final Rejection | WEST CHINA HOSPITAL OF SICHUAN UNIVERSITY |
| 18155281 | METHODS OF EXTENDING LIFESPAN BY ADMINISTERING FERROPTOSIS INHIBITORS | Non-Final OA | COLLABORATIVE MEDICINAL DEVELOPMENT, LLC |
| 17438158 | Heteroaromatic and Heterobicyclic Aromatic Derivatives for the Treatment of Ferroptosis-Related Disorders | Non-Final OA | COLLABORATIVE MEDICINAL DEVELOPMENT, LLC |
| 18060323 | COMPOSITIONS COMPRISING LACTATE DEHYDROGENASE-A INHIBITORS AND METHODS OF PRODUCTION AND USE THEREOF | Non-Final OA | Southwestern Oklahoma State University |
| 17996028 | CRYSTALLINE RET INHIBITOR | Final Rejection | Loxo Oncology, Inc. |
| 17802558 | Pharmaceutical compositions comprising 2-[(4S)-8-fluoro-2-[4-(3-methoxyphenyl)piperazin-1-yl]-3-[2-methoxy-5-(trifluoromethyl)phenyl]-4H-quinazolin-4-yl]acetate and sodium ions | Final Rejection | AIC246 AG & Co. KG |
| 17309450 | METHODS OF MODULATING LEUKOCYTES ACTIVATION AND THROMBOCYTE CLEARANCE WITH INHIBITORS OF SPECIFIC NEURAMINIDASE ISOENZYMES | Final Rejection | Valorisation HSJ, Limited Partnership |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy